Neurocognitive dysfunction in children with neurofibromatosis type 1.
about
Alternative splicing of the neurofibromatosis type I pre-mRNAReduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.Cognitive profile of children with neurofibromatosis and reading disabilities.Understanding intellectual disability through RASopathies.Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent mannerPerfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway.Molecular and cellular mechanisms of learning disabilities: a focus on NF1.Behavioral profiles of mouse models for autism spectrum disorders.Inhibition and termination of physiological responses by GTPase activating proteins.Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attentionTesting the excitation/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes.Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity.Early grade repetition and inattention associated with neurofibromatosis type 1.Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se
P2860
Q26865241-9F9D64E7-EE58-4F53-92BE-994959084B6CQ30497049-434F4515-159A-46AA-A3DF-1FAC4E98E868Q34088590-B20169A2-E90D-4122-9E00-DF5F5653F2D6Q34558084-75A01E51-8BE6-401C-B299-A356920BB9F1Q35613659-6E7222B5-51DF-4752-9140-A4D46EF043E1Q35925439-E31BD6F0-95CB-42EC-8DC2-8AADD0E79D49Q36118445-A10A94D7-7964-42EE-812E-DE4DC2B3050CQ37719525-76F9109B-7E6B-46FA-A438-1D3515EDF471Q37844007-C1428684-0814-4EDD-9F4E-C4B6DD34F9C8Q37980724-8CF9CFA0-D47C-478C-B78B-66631F237C3CQ38831064-F30C8D45-95DA-4ADE-9891-4E53B77C49F5Q41716345-4557CC4F-30FD-457C-ACA4-AD4BAB563928Q47140291-F4F863F0-BE6D-4EC6-827A-B2F4DD1ACD0EQ51915194-0248DCB0-1069-477E-9FC7-BF334371A4B1Q57581441-D44B2BB4-EBE6-4B71-8736-8A0322E0B3A0
P2860
Neurocognitive dysfunction in children with neurofibromatosis type 1.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@ast
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@en
type
label
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@ast
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@en
prefLabel
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@ast
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@en
P2860
P1476
Neurocognitive dysfunction in children with neurofibromatosis type 1.
@en
P2093
Roger J Packer
Tena L Rosser
P2860
P2888
P304
P356
10.1007/S11910-003-0064-3
P577
2003-03-01T00:00:00Z